Clinicians missing ‘critical’ step in Alzheimer’s diagnoses, 2023 report finds
By
Alicia Lasek
Mar 16, 2023
Clinicians are not proactive in engaging patients on the subject of memory concerns, missing a key chance for timely diagnosis and early treatment, finds an Alzheimer’s Association report released...
Expert expects DOJ to ramp up nursing home enforcement efforts after pandemic
By
Danielle Brown
Apr 21, 2020
Providers shouldn’t assume that federal authorities will slow down enforcement efforts in the aftermath of the coronavirus pandemic. In fact, they should expect authorities to “step up” enforcement...
First appropriate use guidance published for Alzheimer’s drug Aduhelm
By
Alicia Lasek
Jul 28, 2021
The new guidelines cover how to choose appropriate patients, safely scale up to a full dose, monitor side effects and assess effectiveness. The authors also address when to stop therapy and what patients...
Immunity from states in COVID-based civil suits won’t protect operators from federal action: expert
By
Danielle Brown
Apr 29, 2020
Providers won’t be immune from potential federal investigations that arise from bad outcomes during the coronavirus pandemic, even though several states have agreed to protect them from future coronavirus-related...
BREAKING: First appropriate use guidance published for Alzheimer’s drug Aduhelm
By
Alicia Lasek
Jul 27, 2021
The first set of guidelines has been published for clinicians who wish to prescribe the new drug aducanumab (Aduhelm) and to properly monitor its administration. The recommendations fill the gaps between...
Alzheimer’s drug donanemab finds late-stage trial success, safety concerns
By
Alicia Lasek
May 04, 2023
The experimental drug donanemab appears to halt the progression of Alzheimer’s disease and slow certain measures of clinical decline, new trial data show.
FDA approves first drug to slow Alzheimer’s in controversial decision
By
Alicia Lasek
Jun 07, 2021
The evidence convincingly shows that aducanumab (Aduhelm) removes beta amyloid — a hallmark of Alzheimer’s — from the brain, slowing the disease’s progression and giving patients and families much-needed...
Preparing for litigation after COVID-19
By
Rebecca A. Brommel
Andrew Brantingham
Nov 09, 2020
Long-term care facilities have been in the fight of their lives – and for the lives of their residents – since March. In addition to the usual regulatory requirements, facilities must deal with COVID-19...